Boguslaw Nocek
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Boguslaw Nocek has a total of 15 co-authors. Here are the top co-authors by number of shared publications:
- Andrzej Joachimiak
BERlight and Structural Biology Center, X-ray Science Division, Advanced Photon Source, Argonne National Laboratory, Lemont, Illinois, USA
1 shared publication - Besnik Bajrami
Broad Institute of MIT and Harvard, Cambridge, MA 02141, USA
1 shared publication - Catherine Hatzos-Skintges
Center for Structural Genomics of Infectious Diseases, University of Chicago, Chicago, IL 60367, USA
1 shared publication - Changsoo Chang
Structural Biology Center, X-ray Science Division, Argonne National Laboratory, Lemont, USA
1 shared publication - Deborah T. Hung
Broad Institute of MIT and Harvard, Cambridge, USA
1 shared publication - Grazyna Joachimiak
Midwest Center for Structural Genomics, Biosciences Division, Argonne National Laboratory, Argonne, IL 60439, USA
1 shared publication
Latest Publications
- Open Access
- 29 May 2019
- Published by International Union of Crystallography (IUCr) in IUCrJ
- Vol. 6 (4) , 649-664
Conservation of the structure and function of bacterial tryptophan synthases
Tryptophan biosynthesis is one of the most characterized processes in bacteria, in which the enzymes fromSalmonella typhimuriumandEscherichia coliserve as model systems. Tryptophan synthase (TrpAB) catalyzes the final two steps of tryptophan biosynthesis in plants, fungi and bacteria. This pyridoxal 5′-phosphate (PLP)-dependent enzyme consists of two protein chains, α (TrpA) and β (TrpB), functioning as a linear αββα heterotetrameric complex containing two TrpAB units. The reaction has a complicated, multistep mechanism resulting in the β-replacement of the hydroxyl group of L-serine with an indole moiety. Recent studies have shown that functional TrpAB is required for the survival of pathogenic bacteria in macrophages and for evading host defense. Therefore, TrpAB is a promising target for drug discovery, as its orthologs include enzymes from the important human pathogensStreptococcus pneumoniae,Legionella pneumophilaandFrancisella tularensis, the causative agents of pneumonia, legionnaires' disease and tularemia, respectively. However, specific biochemical and structural properties of the TrpABs from these organisms have not been investigated. To fill the important phylogenetic gaps in the understanding of TrpABs and to uncover unique features of TrpAB orthologs to spearhead future drug-discovery efforts, the TrpABs fromL. pneumophila,F. tularensisandS. pneumoniaehave been characterized. In addition to kinetic properties and inhibitor-sensitivity data, structural information gathered using X-ray crystallography is presented. The enzymes show remarkable structural conservation, but at the same time display local differences in both their catalytic and allosteric sites that may be responsible for the observed differences in catalysis and inhibitor binding. This functional dissimilarity may be exploited in the design of species-specific enzyme inhibitors.
- 29 May 2019
- Published by International Union of Crystallography (IUCr) in IUCrJ
- Vol. 6 (4) , 649-664
Open AccessConservation of the structure and function of bacterial tryptophan synthases
Tryptophan biosynthesis is one of the most characterized processes in bacteria, in which the enzymes fromSalmonella typhimuriumandEscherichia coliserve as model systems. Tryptophan synthase (TrpAB) catalyzes the final two steps of tryptophan biosynthesis in plants, fungi and bacteria. This pyridoxal 5′-phosphate (PLP)-dependent enzyme consists of two protein chains, α (TrpA) and β (TrpB), functioning as a linear αββα heterotetrameric complex containing two TrpAB units. The reaction has a complicated, multistep mechanism resulting in the β-replacement of the hydroxyl group of L-serine with an indole moiety. Recent studies have shown that functional TrpAB is required for the survival of pathogenic bacteria in macrophages and for evading host defense. Therefore, TrpAB is a promising target for drug discovery, as its orthologs include enzymes from the important human pathogensStreptococcus pneumoniae,Legionella pneumophilaandFrancisella tularensis, the causative agents of pneumonia, legionnaires' disease and tularemia, respectively. However, specific biochemical and structural properties of the TrpABs from these organisms have not been investigated. To fill the important phylogenetic gaps in the understanding of TrpABs and to uncover unique features of TrpAB orthologs to spearhead future drug-discovery efforts, the TrpABs fromL. pneumophila,F. tularensisandS. pneumoniaehave been characterized. In addition to kinetic properties and inhibitor-sensitivity data, structural information gathered using X-ray crystallography is presented. The enzymes show remarkable structural conservation, but at the same time display local differences in both their catalytic and allosteric sites that may be responsible for the observed differences in catalysis and inhibitor binding. This functional dissimilarity may be exploited in the design of species-specific enzyme inhibitors.